1.A multi-stage and multi-epitope vaccine against Mycobacterium tuberculosis based on an immunoinformatics approach.
Yu NING ; Yihan CAI ; Xiaoling LIU ; Chenchen GU ; Xiangying MENG ; Jinjuan QIAO
Chinese Journal of Cellular and Molecular Immunology 2023;39(6):494-500
Objectives To develop a multi-stage and multi-epitope vaccine, which consists of epitopes from the early secretory and latency-associated antigens of Mycobacterium tuberculosis (MTB). Methods The B-cell, cytotoxic T-lymphocyte (CTL) and helper T-lymphocyte (HTL) epitopes of 12 proteins were predicted using an immunoinformatics. The epitopes with antigenicity, without cytotoxicity and sensitization, were further screened to construct the multi-epitope vaccine. Furthermore, the proposed vaccine underwent physicochemical properties analysis and secondary structure prediction as well as 3D structure modeling, refinement and validation. Then the refined model was docked with TLR4. Finally, an immune simulation of the vaccine was carried out. Results The proposed vaccine, which consists of 12 B-cell, 11 CTL and 12 HTL epitopes, had a flexible and stable globular conformation as well as a thermostable and hydrophilic structure. A stable interaction of the vaccine with TLR4 was confirmed by molecular docking. The efficiency of the candidate vaccine to trigger effective cellular and humoral immune responses was assessed by immune simulation. Conclusion A multi-stage multi-epitope MTB vaccine construction strategy based on immunoinformatics is proposed, which is expected to prevent both active and latent MTB infection.
Mycobacterium tuberculosis/metabolism*
;
Molecular Docking Simulation
;
Toll-Like Receptor 4
;
Epitopes, T-Lymphocyte/chemistry*
;
Epitopes, B-Lymphocyte/chemistry*
;
Vaccines, Subunit/chemistry*
;
Computational Biology/methods*
2.Prokaryotic expression of the GapC protein of Streptococcus uberis and prediction, identification of its B-cell epitopes.
Hanqing WANG ; Xuejing ZHANG ; Huan ZHANG ; Xiaomeng CHEN ; Baojiang ZHANG ; Yan SU
Chinese Journal of Biotechnology 2022;38(1):148-159
The GapC protein of Streptococcus uberis located on the surface of bacteria is a protein with glyceraldehyde-3-phosphate dehydrogenase activity. It participates in cellular processes and exhibits a variety of biological activities. In addition, it has good antigenicity. The aim of this study was to predict the possible B-cell epitopes of the GapC protein and verify the immunogenicity of candidate epitope peptides. The gapC gene of S. uberis isolate RF5-1 was cloned into a recombinant expression plasmid pET-28a-GapC and inducibly expressed. The purified protein was used to immunize experimental rabbits to produce anti-GapC polyclonal antibodies. The three-dimensional structure and three-dimensional location of the GapC B-cell epitopes and the homology comparison of the GapC protein and its B-cell epitopes were carried out using bioinformatics softwares. The results showed that the 44-kDa GapC protein had a good immunological reactivity. Six linear and 3 conformational dominant B-cell epitopes against the GapC protein were selected and synthesized. Three dimensional analysis indicated that the selected peptides have better antigen epitope formation potential. Rabbit anti-GapC polyclonal antibodies were generated after immunized with the purified GapC protein, and the polyclonal antibodies were used to identify the epitope peptide by an indirect ELISA. The ELISA results showed that all of the 9 epitope peptides could react with anti-GapC polyclonal antibodies with varying titers. Among them, the epitope polypeptide 266AANDSYGYTEDPIVSSD282 reacted with the polyclonal antibodies significantly stronger than with other epitope peptides. This study laid an experimental foundation for in-depth understanding of the immunological properties and utilizing effective epitopes of the GapC protein of S. uberis.
Animals
;
Antigens, Bacterial/genetics*
;
Bacterial Proteins/genetics*
;
Epitopes, B-Lymphocyte/genetics*
;
Mice
;
Mice, Inbred BALB C
;
Rabbits
;
Streptococcus
3.Polymorphism of P66 in
Qin HAO ; Hui Xin LIU ; Xue Xia HOU ; Lin ZHANG ; Xiao Na YANG ; Kang Lin WAN
Biomedical and Environmental Sciences 2021;34(5):364-371
Objective:
To study the polymorphism in P66 and its human B-cell epitopes of
Methods:
Polymerase chain reaction (PCR) and sequencing were used to obtain the P66 sequences of 59 Chinese
Results:
Results showed that genetic and amino acid diversity presented in the 66 kD protein of all 59 Chinese strains, especially in
Conclusion
In P66 of 59 Chinese strains, polymorphisms were widely distributed. More importantly, the P66 amino acid sequences of
Bacterial Proteins/genetics*
;
Borrelia burgdorferi/genetics*
;
China
;
Cluster Analysis
;
Epitopes, B-Lymphocyte/genetics*
;
Genetic Markers
;
Genotype
;
Humans
;
Mutation
;
Polymerase Chain Reaction
;
Polymorphism, Genetic
;
Porins/genetics*
4.Multi-Epitope Fusion Protein Eg mefAg-1 as a Serodiagnostic Candidate for Cystic Echinococcosis in Sheep
Liu TIANLI ; Wang XIFENG ; Tian ZHENZHONG ; Wang LIXIA ; Zhang XINGXING ; Qiao JUN ; Meng QINGLING ; Gong SHASHA ; Chen YING ; Cai XUEPENG
The Korean Journal of Parasitology 2019;57(1):61-67
Cystic echinococcosis (CE) in sheep is a hazardous zoonotic parasitic disease that is caused by Echinococcus granulosus (Eg). At present, serological test is an important diagnostic method for Eg infection in domestic animals. Here, a fusion protein Eg mefAg-1 harboring 8 dominant B-cell epitopes of Eg such as antigen B, tetraspanin 1, tetraspanin 6, reticulon and Eg95 was produced in E. coli and evaluated for CE in sheep by indirect ELISA. Eg mefAg-1 showed in ELISA a high sensitivity (93.41%) and specificity (99.31%), with a coincidence rate of 97.02%. Overall, it is suggested that the Eg mefAg-1 could be a potential antigen candidate for CE serodiagnosis in sheep.
Animals, Domestic
;
Echinococcosis
;
Echinococcus granulosus
;
Enzyme-Linked Immunosorbent Assay
;
Epitopes, B-Lymphocyte
;
Methods
;
Parasitic Diseases
;
Sensitivity and Specificity
;
Serologic Tests
;
Sheep
5.Development of a Novel Subunit Vaccine Targeting Fusobacterium nucleatum FomA Porin Based on In Silico Analysis.
Kwangjoon JEONG ; Puth SAO ; Mi Jin PARK ; Hansol LEE ; Shi Ho KIM ; Joon Haeng RHEE ; Shee Eun LEE
International Journal of Oral Biology 2017;42(2):63-70
Selecting an appropriate antigen with optimal immunogenicity and physicochemical properties is a pivotal factor to develop a protein based subunit vaccine. Despite rapid progress in modern molecular cloning and recombinant protein technology, there remains a huge challenge for purifying and using protein antigens rich in hydrophobic domains, such as membrane associated proteins. To overcome current limitations using hydrophobic proteins as vaccine antigens, we adopted in silico analyses which included bioinformatic prediction and sequence-based protein 3D structure modeling, to develop a novel periodontitis subunit vaccine against the outer membrane protein FomA of Fusobacterium nucleatum. To generate an optimal antigen candidate, we predicted hydrophilicity and B cell epitope parameter by querying to web-based databases, and designed a truncated FomA (tFomA) candidate with better solubility and preserved B cell epitopes. The truncated recombinant protein was engineered to expose epitopes on the surface through simulating amino acid sequence-based 3D folding in aqueous environment. The recombinant tFomA was further expressed and purified, and its immunological properties were evaluated. In the mice intranasal vaccination study, tFomA significantly induced antigen-specific IgG and sIgA responses in both systemic and oral-mucosal compartments, respectively. Our results testify that intelligent in silico designing of antigens provide amenable vaccine epitopes from hard-to-manufacture hydrophobic domain rich microbial antigens.
Animals
;
Cloning, Molecular
;
Computational Biology
;
Computer Simulation*
;
Epitopes
;
Epitopes, B-Lymphocyte
;
Fusobacterium nucleatum*
;
Fusobacterium*
;
Hydrophobic and Hydrophilic Interactions
;
Immunoglobulin A, Secretory
;
Immunoglobulin G
;
Membrane Proteins
;
Mice
;
Periodontitis
;
Solubility
;
Vaccination
6.DNA Vaccines Encoding Toxoplasma gondii Cathepsin C 1 Induce Protection against Toxoplasmosis in Mice.
Yali HAN ; Aihua ZHOU ; Gang LU ; Guanghui ZHAO ; Wenchao SHA ; Lin WANG ; Jingjing GUO ; Jian ZHOU ; Huaiyu ZHOU ; Hua CONG ; Shenyi HE
The Korean Journal of Parasitology 2017;55(5):505-512
Toxoplasma gondii cathepsin C proteases (TgCPC1, 2, and 3) are important for the growth and survival of T. gondii. In the present study, B-cell and T-cell epitopes of TgCPC1 were predicted using DNAstar and the Immune Epitope Database. A TgCPC1 DNA vaccine was constructed, and its ability to induce protective immune responses against toxoplasmosis in BALB/c mice was evaluated in the presence or absence of the adjuvant α-GalCer. As results, TgCPC1 DNA vaccine with or without adjuvant α-GalCer showed higher levels of IgG and IgG2a in the serum, as well as IL-2 and IFN-γ in the spleen compared to controls (PBS, pEGFP-C1, and α-Galcer). Upon challenge infection with tachyzoites of T. gondii (RH), pCPC1/α-Galcer immunized mice showed the longest survival among all the groups. Mice vaccinated with DNA vaccine without adjuvant (pCPC1) showed better protective immunity compared to other controls (PBS, pEGFP-C1, and α-Galcer). These results indicate that a DNA vaccine encoding TgCPC1 is a potential vaccine candidate against toxoplasmosis.
Animals
;
B-Lymphocytes
;
Cathepsin C*
;
Cathepsins*
;
DNA*
;
Epitopes, T-Lymphocyte
;
Immunoglobulin G
;
Interleukin-2
;
Mice*
;
Peptide Hydrolases
;
Spleen
;
Toxoplasma*
;
Toxoplasmosis*
;
Vaccines, DNA*
7.Bioinformatic analysis of non-VP1 capsid protein of coxsackievirus A6.
Hong-Bo LIU ; Guang-Fei YANG ; Si-Jia LIANG ; Jun LIN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2016;36(4):607-613
This study bioinformatically analyzed the non-VP1 capsid proteins (VP2-VP4) of Coxasckievirus A6 (CVA6), with an attempt to predict their basic physicochemical properties, structural/functional features and linear B cell eiptopes. The online tools SubLoc, TargetP and the others from ExPASy Bioinformatics Resource Portal, and SWISS-MODEL (an online protein structure modeling server), were utilized to analyze the amino acid (AA) sequences of VP2-VP4 proteins of CVA6. Our results showed that the VP proteins of CVA6 were all of hydrophilic nature, contained phosphorylation and glycosylation sites and harbored no signal peptide sequences and acetylation sites. Except VP3, the other proteins did not have transmembrane helix structure and nuclear localization signal sequences. Random coils were the major conformation of the secondary structure of the capsid proteins. Analysis of the linear B cell epitopes by employing Bepipred showed that the average antigenic indices (AI) of individual VP proteins were all greater than 0 and the average AI of VP4 was substantially higher than that of VP2 and VP3. The VP proteins all contained a number of potential B cell epitopes and some eiptopes were located at the internal side of the viral capsid or were buried. We successfully predicted the fundamental physicochemical properties, structural/functional features and the linear B cell eiptopes and found that different VP proteins share some common features and each has its unique attributes. These findings will help us understand the pathogenicity of CVA6 and develop related vaccines and immunodiagnostic reagents.
Amino Acid Sequence
;
Capsid Proteins
;
genetics
;
immunology
;
Computational Biology
;
Enterovirus
;
genetics
;
pathogenicity
;
Epitopes, B-Lymphocyte
;
genetics
;
immunology
;
Humans
8.Identifying Novel B Cell Epitopes within Toxoplasma gondii GRA6.
Yanhua WANG ; Guangxiang WANG ; Jian Ping CAI
The Korean Journal of Parasitology 2016;54(4):431-437
The study of antigenic epitopes from Toxoplasma gondii has not only enhanced our understanding of the structure and function of antigens, the reactions between antigens and antibodies, and many other aspects of immunology, but it also plays a significant role in the development of new diagnostic reagents and vaccines. In the present study, T. gondii GRA6 epitopes were identified using bioinformatics tools and a synthetic peptide technique. The potential B cell epitopes of GRA6 predicted by bioinformatics tools concentrated upon 3 regions of GRA6, 1-20 aa, 44-103 aa, and 172-221 aa. Ten shorter peptides from the 3 regions were synthesized and assessed by ELISA using pig sera from different time points after infection. Three of the 10 peptides (amino acids 44-63, 172-191, and 192-211) tested were recognized by all sera and determined to be immunodominant B-cell epitopes of GRA6. The results indicated that we precisely and accurately located the T. gondii GRA6 epitopes using pig sera collected at different time points after infection. The identified epitopes may be very useful for further studies of epitope-based vaccines and diagnostic reagents.
Allergy and Immunology
;
Antibodies
;
Computational Biology
;
Enzyme-Linked Immunosorbent Assay
;
Epitopes
;
Epitopes, B-Lymphocyte*
;
Indicators and Reagents
;
Peptides
;
Toxoplasma*
;
Vaccines
9.In silico analysis of Brucella abortus Omp2b and in vitro expression of SOmp2b.
Maryam GOLSHANI ; Nafise VAEZNIA ; Mehdi SAHMANI ; Saeid BOUZARI
Clinical and Experimental Vaccine Research 2016;5(1):75-82
PURPOSE: At present, there is no vaccine available for the prevention of human brucellosis. Brucella outer membrane protein 2b (Omp2b) is a 36 kD porin existed in common Brucella pathogens and it is considered as priority antigen for designing a new subunit vaccine. MATERIALS AND METHODS: In the current study, we aimed to predict and analyze the secondary and tertiary structures of the Brucella abortus Omp2b protein, and to predict T-cell and B-cell epitopes with the help of bioinformatics tools. Subsequently, cloning and expression of the short form of Omp2b (SOmp2b) was performed using pET28a expression vector and Escherichia coli BL21 host, respectively. The recombinant SOmp2b (rSOmp2b) was purified with Ni-NTA column. RESULTS: The recombinant protein was successfully expressed in E. coli host and purified under denaturation conditions. The yield of the purified rSOmp2b was estimated by Bradford method and found to be 220 microg/mL of the culture. CONCLUSION: Our results indicate that Omp2b protein has a potential to induce both B-cell- and T-cell-mediated immune responses and it can be evaluated as a new subunit vaccine candidate against brucellosis.
Brucella abortus*
;
Brucella*
;
Brucellosis
;
Clone Cells
;
Cloning, Organism
;
Computational Biology
;
Computer Simulation*
;
Epitopes, B-Lymphocyte
;
Escherichia coli
;
Humans
;
Membrane Proteins
;
T-Lymphocytes
10.Accelerating the development of a group A Streptococcus vaccine: an urgent public health need.
Jean Louis EXCLER ; Jerome H KIM
Clinical and Experimental Vaccine Research 2016;5(2):101-107
Group A Streptococcus (GAS) infections cause substantial worldwide morbidity and mortality, mostly associated with suppurative complications such as pharyngitis, impetigo, and non-suppurative immune syndromes such as acute rheumatic fever, rheumatic heart disease, and acute post-streptococcal glomerulonephritis. Deaths occur mostly in children, adolescents, and young adults in particular pregnant women in low- and middle-income countries. GAS strains are highly variable, and a GAS vaccine would need to overcome the issue of multiple strains. Several approaches have been used multivalent vaccines using N-terminal polypeptides of different M protein; conserved M protein vaccines with antigens from the conserved C-repeat portion of the M protein; incorporation selected T- and B-cell epitopes from the C-repeat region in a synthetic polypeptide or shorter single minimal B-cell epitopes from this same region; and non-M protein approaches utilizing highly conserved motives of streptococcal C5a peptidase, GAS carbohydrate and streptococcal fibronectin-binding proteins. A GAS vaccine represents urgent need for this neglected disease and should therefore deserve the greatest attention of international organizations, donors, and vaccine manufacturers.
Adolescent
;
Child
;
Epitopes, B-Lymphocyte
;
Female
;
Glomerulonephritis
;
Humans
;
Impetigo
;
Mortality
;
Neglected Diseases
;
Peptides
;
Pharyngitis
;
Pregnant Women
;
Public Health*
;
Rheumatic Fever
;
Rheumatic Heart Disease
;
Streptococcus*
;
Tissue Donors
;
Vaccines
;
Young Adult

Result Analysis
Print
Save
E-mail